Vimarsana
Biggest News Aggregation in the World

Term Efficacy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Term Efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Term Efficacy Today - Breaking & Trending Today

Vaccine Against Urinary Tract Infections in Development - Vimarsana News

Vaccine Against Urinary Tract Infections in Development

A randomized study published in 2022 showed the vaccine's efficacy in preventing urinary tract infections over 9 months.

Dermatology Month in Review: January 2024 - Vimarsana News

Dermatology Month in Review: January 2024

January’s Dermatology Month in Review features 2 major FDA decisions, positive results on a new assessment tool, an evaluation of climate change’s impact on eczema, and more.

The Week in Review: December 4-8 - Vimarsana News

The Week in Review: December 4-8

From adjunctive cariprazine for the treatment of major depressive disorder to a new app for prescribing antidepressants and antipsychotics, here are highlights from the week in Psychiatric Times.

Adjunctive Cariprazine in Treating Major Depressive Disorder - Vimarsana News

Adjunctive Cariprazine in Treating Major Depressive Disorder

This ACNP 2023 Annual Meeting poster covered a 26-week study on cariprazine as an adjunctive treatment to antidepressants in patients with major depressive disorder.

Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting - Vimarsana News

Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting

SEATTLE, Dec. 05, 2023 -- Adaptive Biotechnologies Corporation , a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to...